These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6973308)

  • 1. [Findings on the behavior of beta 1 SP 1 in normal and complicated pregnancies].
    Guaschino S; Pesando PC; Montanari L; Bolis PF; Imbriani M
    Ann Ostet Ginecol Med Perinat; 1981; 102(2):95-9. PubMed ID: 6973308
    [No Abstract]   [Full Text] [Related]  

  • 2. [Do pregnancy proteins have prospective significance? (SP-1, HPL and PP-5)].
    Tatra G; Lüben G; Nasr F
    Geburtshilfe Frauenheilkd; 1985 Jun; 45(6):363-6. PubMed ID: 3874806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [High molecular weight albumins in normal and pathological pregnancies and under tocolytic therapy. Serum concentrations of beta-1-SP-1, IgM and alpha-2-macroglobulin].
    Siekmann U; Heilmann L
    Fortschr Med; 1980 Nov; 98(41):1614-7. PubMed ID: 6162765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of pregnancy protein estimations with particular reference to pregnancy-associated plasma protein A (PAPP-A).
    Stabile I; Grudzinskas JG; Chard T
    Obstet Gynecol Surv; 1988 Feb; 43(2):73-82. PubMed ID: 2448714
    [No Abstract]   [Full Text] [Related]  

  • 5. Daily antenatal cardiotocography in the management of high-risk pregnancies.
    Weiss DB; Pugh C; Simmons SC
    Int Surg; 1977 Sep; 62(9):470-5. PubMed ID: 908631
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating levels of pregnancy specific beta 1-glycoprotein in normal & pathological pregnancies.
    Majumdar S; Dahiya R; Mapa MK; Gopalan S; Devi PK
    Indian J Med Res; 1984 May; 79():630-5. PubMed ID: 6334651
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of cardiotocographic studies in threatened premature labor and intrauterine retardation. A contribution to respiratory placental insufficiency].
    Ruckhäberle KE; Pfeiffer R; Forberg J; Viehweg B
    Zentralbl Gynakol; 1986; 108(12):744-55. PubMed ID: 3751382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregnancy-specific beta 1-glycoprotein, HCG alpha subunit, alpha fetoproteins and HPL in fetal hypotrophy].
    Ruseva R; Marinov B; Milkov V; Milanov S
    Akush Ginekol (Sofiia); 1984; 23(4):315-20. PubMed ID: 6207743
    [No Abstract]   [Full Text] [Related]  

  • 9. New placental proteins in placental dysfunction.
    Lee JN; Chard T
    Contrib Gynecol Obstet; 1982; 9():157-69. PubMed ID: 6183052
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prognostic potentials of pregnancy-specific beta l-glycoprotein in retarded fetal growth].
    Ruseva R; Marinov B
    Akush Ginekol (Sofiia); 1983; 22(4):277-81. PubMed ID: 6608281
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma levels of HCS and beta SP1 in normal and pathological pregnancies].
    Merger C; Guinot N; Blanc B; Ruf H
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):573-82. PubMed ID: 6757310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of placental protein 5, placental lactogen and pregnancy-specific beta 1 glycoprotein in mid-trimester as a predictor of outcome of pregnancy.
    Salem HT; Lee JN; Seppälä M; Vaara L; Aula P; Al-Ani AT; Chard T
    Br J Obstet Gynaecol; 1981 Apr; 88(4):371-4. PubMed ID: 6971651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal serum levels of placental protein 5 in complications of late pregnancy.
    Salem HT; Westergaard JG; Hindersson P; Lee JN; Grudzinskas JG; Chard T
    Obstet Gynecol; 1982 Apr; 59(4):467-71. PubMed ID: 7078900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of placental protein 10 (PP 10) in maternal serum in normal and pathologic pregnancies.
    Takayama M; Soma H; Okudera K; Isaka K; Sayama S; Kashiwagi H; Ogawa T; Yamabe S
    Biol Res Pregnancy Perinatol; 1985; 6(4):168-72. PubMed ID: 4063432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Placental oxytocinase and alkaline phosphatase activities and the SP1-glycoprotein level in pregnancy complicated by intrauterine fetal growth retardation].
    Gabryś M; Woytoń J; Lemańska K; Riess A; Bielanów T
    Ginekol Pol; 1986 Nov; 57(11):723-6. PubMed ID: 3493952
    [No Abstract]   [Full Text] [Related]  

  • 16. Circulating placental proteins in pregnancies complicated by RH isoimmunization.
    Lee JN; Huang SC; Ouyang PC; Chard T
    Obstet Gynecol; 1984 Jul; 64(1):131-2. PubMed ID: 6429588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human placental lactogen and other placental proteins as indicators of fetal well-being.
    Varner MW; Hauser KS
    Clin Obstet Gynecol; 1982 Dec; 25(4):673-88. PubMed ID: 6186425
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunological assay of beta-1-SP-1-glycoprotein applied to obstetric diagnosis: review of the literature and serum levels in normal and pathological pregnancies].
    Guerresi E; Mazzanti C; Altobelli L; Beccari A; Gori G
    Riv Ital Ginecol; 1980; 59(1):29-35. PubMed ID: 7008166
    [No Abstract]   [Full Text] [Related]  

  • 19. Pregnancy-specific beta 1-glycoprotein as a screening test for at-risk pregnancies.
    Chapman MG; O'Shea RT; Jones WR; Hillier R
    Am J Obstet Gynecol; 1981 Nov; 141(5):499-502. PubMed ID: 6170225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monitoring of HPL, estriol and estetrol in high-risk pregnancy].
    Gherzi R; Pastore M; Labate D
    Minerva Ginecol; 1981 Oct; 33(10):911-6. PubMed ID: 7312213
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.